Delivery Order SPE2DB22D1041-SPE2DB24FTZX4

Award Date 2/21/24
Potential Completion Date 3/13/24
Potential Value $15K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide VARIVAX vaccine with diluents. The contract has a potential value of $8,603.73 and a completion date of March 12, 2024. Amerisourcebergen Drug Corp is the prime contractor for this delivery order, which is not associated with any set-aside program. Additionally, Amerisourcebergen Drug Corp holds an indefinite delivery...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide VARIVAX vaccine with diluents. The contract has a potential value of $2,867.91 and a completion date of March 12, 2024. Amerisourcebergen Drug Corp is the prime contractor on this delivery order contract, which is part of a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00 that the company holds...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of VARIVAX vaccine with diluents. The contract has a completion date of March 20, 2024 and a potential value of $9,559.80. Amerisourcebergen Drug Corp, located in Conshohocken, Pennsylvania, is a for-profit organization that serves as a prime contractor providing pharmaceutical products and medical supplies to...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of VARIVAX vaccine with diluents. The delivery order has a potential value of $67,022.38 and a completion date of March 12, 2024. Amerisourcebergen Drug Corp serves as the prime contractor for this contract, which is not associated with any set-aside program. Amerisourcebergen Drug Corp holds a larger indefinite delivery...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a wholly-owned subsidiary of Amerisourcebergen Corporation, to provide VARIVAX vaccine with diluents. The $5,735.82 contract has a completion date of March 28, 2024. Amerisourcebergen Drug Corp is the prime contractor and there is no indication of any set-aside designation for this award. The delivery order was issued under an indefinite delivery contract (IDC) with a potential value of...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide VARIVAX vaccine with diluents. The contract has a potential value of $76,477.60 and a period of performance through March 13, 2024. Amerisourcebergen Drug Corp is the prime contractor and there is no set-aside designation. This order is issued under a larger indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00,...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of the VARIVAX vaccine with diluents. The contract, valued at $1,911.94, has an ultimate completion date of April 2, 2024. Amerisourcebergen Drug Corp, a for-profit organization, serves as the prime contractor on this delivery order, which is part of a larger, single-award indefinite delivery...
The U.S. Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a firm fixed price delivery order valued at $1,911.94 to provide VARIVAX vaccine with diluents. This award is part of a larger indefinite delivery contract (IDC) between DLA and Amerisourcebergen Drug Corp, valued up to $999,999,999.00 through December 31, 2025, for the provision of pharmaceutical products and medical supplies to DLA Troop Support Medical facilities...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of VARIVAX vaccine with diluents. The contract has a potential value of $3,823.88 and a performance period through March 21, 2024. Amerisourcebergen Drug Corp is the prime contractor on this delivery order, which is part of a larger indefinite delivery contract (IDC) valued up to $999,999,999.00 awarded by DLA to...
The Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide VARIVAX vaccine with diluents. The contract is a firm fixed price award with a ceiling value of $1,911.94 and a performance period through April 3, 2024. AmerisourceBergen Drug Corp is the prime contractor for this delivery order, which is part of a larger indefinite delivery contract (IDC) with DLA valued at up to $999,999,999.00...
  • SPE2DB22D1041
    Indefinite Delivery Contract
  • SPE2DB22D1041-SPE2DB24FTZX4
    Delivery Order

The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $15,295.52 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of VARIVAX Vaccine with Diluents. The contract has a completion date of March 13, 2024. Amerisourcebergen Drug Corp is the prime contractor and there were no set-aside designations used. This award is likely part of a larger indefinite delivery contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen Drug Corp holds with DLA, which serves as the primary vehicle for the company to deliver pharmaceutical products and medical supplies to support Department of Defense military treatment programs and facilities worldwide.

Generated 5/22/24, 10:01 AM